Lee Kevin, CEO of Bicycle Therapeutics PLC ($BCYC), made eight open market sales of company shares over the past year, totaling about $271,000. His most recent transaction occurred on January 5, 2026. These sales rank 7,787th among 11,678 individual insiders in the database, well below the average of $8.6 million and 6.4 transactions per insider. He reported no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | BICYCLE THERAPEUTICS PLC | $BCYC | Lee Kevin | CHIEF EXECUTIVE OFFICER | A | Employee Stock Option (right to buy) | 330000 | $0.00 | 330,000.0000 | 69,303,746 | 9999.99% | 0.48% |
| Jan. 5, 2026 | BICYCLE THERAPEUTICS PLC | $BCYC | Lee Kevin | CHIEF EXECUTIVE OFFICER | S | Ordinary Shares | 10989 | $6.46 | 618,996.0000 | 69,303,746 | 1.74% | 0.02% |
| Jan. 2, 2026 | BICYCLE THERAPEUTICS PLC | $BCYC | Lee Kevin | CHIEF EXECUTIVE OFFICER | S | Ordinary Shares | 10325 | $6.80 | 629,985.0000 | 69,303,746 | 1.61% | 0.01% |
| Jan. 2, 2026 | BICYCLE THERAPEUTICS PLC | $BCYC | Lee Kevin | CHIEF EXECUTIVE OFFICER | A | Ordinary Shares | 165000 | $0.00 | 640,310.0000 | 69,303,746 | 34.71% | 0.24% |
| Oct. 3, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Lee Kevin | CHIEF EXECUTIVE OFFICER | S | Ordinary Shares | 3231 | $8.41 | 475,310.0000 | 69,303,746 | 0.68% | 0.00% |
| Oct. 2, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Lee Kevin | CHIEF EXECUTIVE OFFICER | S | Ordinary Shares | 2263 | $8.40 | 478,541.0000 | 69,303,746 | 0.47% | 0.00% |
| July 2, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Lee Kevin | CHIEF EXECUTIVE OFFICER | S | Ordinary Shares | 2268 | $7.09 | 483,997.0000 | 69,252,009 | 0.47% | 0.00% |
| July 3, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Lee Kevin | CHIEF EXECUTIVE OFFICER | S | Ordinary Shares | 3193 | $7.44 | 480,804.0000 | 69,252,009 | 0.66% | 0.00% |
| April 2, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Lee Kevin | CHIEF EXECUTIVE OFFICER | S | Ordinary Shares | 2237 | $8.02 | 489,697.0000 | 69,196,945 | 0.45% | 0.00% |
| April 3, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Lee Kevin | CHIEF EXECUTIVE OFFICER | S | Ordinary Shares | 3432 | $7.48 | 486,265.0000 | 69,196,945 | 0.70% | 0.00% |
| Jan. 2, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Lee Kevin | CHIEF EXECUTIVE OFFICER | A | Employee Stock Option (right to buy) | 308000 | $0.00 | 308,000.0000 | 58,207,593 | 9999.99% | 0.53% |
| Jan. 2, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Lee Kevin | CHIEF EXECUTIVE OFFICER | A | Ordinary Shares | 123200 | $0.00 | 504,064.0000 | 58,207,593 | 32.35% | 0.21% |
| Jan. 2, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Lee Kevin | CHIEF EXECUTIVE OFFICER | S | Ordinary Shares | 9038 | $14.09 | 495,026.0000 | 58,207,593 | 1.79% | 0.02% |
| Jan. 3, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Lee Kevin | CHIEF EXECUTIVE OFFICER | S | Ordinary Shares | 3092 | $14.75 | 491,934.0000 | 58,207,593 | 0.62% | 0.01% |
| Oct. 3, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Lee Kevin | CHIEF EXECUTIVE OFFICER | S | Ordinary Shares | 3212 | $22.26 | 380,864.0000 | 68,988,858 | 0.84% | 0.00% |
| July 3, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Lee Kevin | CHIEF EXECUTIVE OFFICER | S | Ordinary Shares | 3194 | $19.64 | 384,076.0000 | 51,992,034 | 0.82% | 0.01% |
| April 3, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Lee Kevin | CHIEF EXECUTIVE OFFICER | S | Ordinary Shares | 3158 | $23.81 | 387,270.0000 | 42,560,091 | 0.81% | 0.01% |
| Jan. 2, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Lee Kevin | Chief Executive Officer | A | Employee Stock Option (right to buy) | 155000 | $0.00 | 155,000.0000 | 35,592,362 | 9999.99% | 0.44% |
| Jan. 3, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Lee Kevin | Chief Executive Officer | S | Ordinary Shares | 8703 | $17.50 | 390,428.0000 | 35,592,362 | 2.18% | 0.02% |
| Jan. 2, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Lee Kevin | Chief Executive Officer | A | Ordinary Shares | 77000 | $0.00 | 399,131.0000 | 35,592,362 | 23.90% | 0.22% |
| Oct. 3, 2023 | BICYCLE THERAPEUTICS PLC | $BCYC | Lee Kevin | Chief Executive Officer | S | Ordinary Shares | 1470 | $20.00 | 322,131.0000 | 39,576,467 | 0.45% | 0.00% |
| July 3, 2023 | BICYCLE THERAPEUTICS PLC | $BCYC | Lee Kevin | Chief Executive Officer | S | Ordinary Shares | 1498 | $25.10 | 323,601.0000 | 30,191,693 | 0.46% | 0.00% |
| April 3, 2023 | BICYCLE THERAPEUTICS PLC | $BCYC | Lee Kevin | Chief Executive Officer | S | Ordinary Shares | 1486 | $21.11 | 325,099.0000 | 30,001,725 | 0.46% | 0.00% |
| Jan. 3, 2023 | BICYCLE THERAPEUTICS PLC | $BCYC | Lee Kevin | Chief Executive Officer | S | Ordinary Shares | 6000 | $29.06 | 326,585.0000 | 29,660,659 | 1.80% | 0.02% |
| Jan. 3, 2023 | BICYCLE THERAPEUTICS PLC | $BCYC | Lee Kevin | Chief Executive Officer | A | Employee Stock Option (right to buy) | 115000 | $0.00 | 115,000.0000 | 29,660,659 | 9999.99% | 0.39% |
| Jan. 3, 2023 | BICYCLE THERAPEUTICS PLC | $BCYC | Lee Kevin | Chief Executive Officer | A | Ordinary Shares | 57500 | $0.00 | 332,585.0000 | 29,660,659 | 20.90% | 0.19% |